NASDAQ:BRBI BR Biopharma (BRBI) Stock Price, News & Analysis $11.70 -0.05 (-0.43%) Closing price 06/5/2026 03:58 PM EasternExtended Trading$11.72 +0.02 (+0.19%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock About BR Biopharma Stock (NASDAQ:BRBI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BR Biopharma alerts:Sign Up Key Stats Today's Range$11.67▼$11.9050-Day Range$11.70▼$16.3952-Week Range$11.67▼$67.01Volume2,955 shsAverage Volume1,363 shsMarket Capitalization$138.18 millionP/E RatioN/ADividend Yield4.36%Price TargetN/AConsensus RatingSell Company Overview BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil. Read More Receive BRBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BR Biopharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BRBI Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com BRBI Stock Analysis - Frequently Asked Questions How have BRBI shares performed this year? BR Biopharma's stock was trading at $14.75 at the beginning of 2026. Since then, BRBI stock has decreased by 20.7% and is now trading at $11.70. How were BR Biopharma's earnings last quarter? BR Biopharma, Inc. (NASDAQ:BRBI) issued its earnings results on Tuesday, March, 31st. The company reported $0.09 earnings per share for the quarter. The business had revenue of $25.95 million for the quarter. Who are BR Biopharma's major shareholders? Top institutional shareholders of BR Biopharma include Acuitas Investments LLC (0.03%). How do I buy shares of BR Biopharma? Shares of BRBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/31/2026Record date for 6/5 Dividend5/19/2026Ex-Dividend for 6/5 Dividend5/19/2026Dividend Payable6/05/2026Today6/07/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:BRBI CIK2058601 Webwww.ri.brpartners.com.br Phone55-11-3704-1000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares11,810,000Free FloatN/AMarket Cap$138.18 million OptionableN/A BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:BRBI) was last updated on 6/8/2026 by MarketBeat.com Staff. From Our PartnersThis ‘Starburst’ Could Be Bigger Than the SpaceX IPOMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIn 30 days, you'll wish you'd read this emailA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredTiny Nasdaq Firm Lands €13.9 Million Semiconductor DealOne small Nasdaq-listed company just landed a 13.9 million euro contract tied to a new advanced-node semicondu...Finplays | SponsoredAmerica's AI Future Needs a Domestic Fuel ChainAI dominance requires power at a scale most investors have not priced in - and nuclear energy is emerging as a...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BR Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BR Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
